Renal Replacement Therapy

Renal replacement therapy (RRT) is a cornerstone in the clinical management of patients with acute kidney injury. Results from different studies agree that early renal support therapy (aimed to support the residual kidney function during early phases of organ dysfunction) may reduce mortality with respect to late RRT (aimed to substitute the complete loss of function during the advanced kidney insufficiency). Although it seems plausible that a timely initiation of RRT may be associated with improved renal and nonrenal outcomes in these patients, there is scarce evidence in literature to exactly identify the most adequate onset timing for RRT.

[1]  D. Oreopoulos,et al.  The physiology of peritoneal dialysis. , 1989, American journal of nephrology.

[2]  Rinaldo Bellomo,et al.  A pilot study of coupled plasma filtration with adsorption in septic shock* , 2002, Critical care medicine.

[3]  U. Maggiore,et al.  Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent , 2002, Intensive Care Medicine.

[4]  P. Peduzzi,et al.  Intensity of renal support in critically ill patients with acute kidney injury. , 2008, The New England journal of medicine.

[5]  M. Tonelli,et al.  Renal replacement therapy in patients with acute renal failure: a systematic review. , 2008, JAMA.

[6]  A. Balbi,et al.  Early nephrology consultation can have an impact on outcome of acute kidney injury patients. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  R. Bellomo,et al.  A pilot randomised controlled comparison of continuous veno–venous haemofiltration and extended daily dialysis with filtration: effect on small solutes and acid–base balance , 2007, Intensive Care Medicine.

[8]  S. Bagshaw,et al.  Citrate Formulation Determines Filter Lifespan during Continuous Veno-Venous Hemofiltration: A Prospective Cohort Study , 2015, Blood Purification.

[9]  S. Zanotti-Cavazzoni,et al.  Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure , 2007 .

[10]  A. Khwaja KDIGO Clinical Practice Guidelines for Acute Kidney Injury , 2012, Nephron Clinical Practice.

[11]  Patrick D. Brophy,et al.  KDOQI US commentary on the 2012 KDIGO (Kidney Disease: Improving Global Outcomes) clinical practice guideline for acute kidney injury , 2013 .

[12]  P. A. Bowen,et al.  Management of post-traumatic acute renal failure with peritoneal dialysis. , 1992, The American surgeon.

[13]  D. Stollery,et al.  Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. , 2005, Kidney international.

[14]  R. Bellomo Do we know the optimal dose for renal replacement therapy in the intensive care unit? , 2006, Kidney international.

[15]  R M Hakim,et al.  Effect of the dialysis membrane in the treatment of patients with acute renal failure. , 1994, The New England journal of medicine.

[16]  T. Scalea,et al.  Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early vs. late , 1999, Intensive Care Medicine.

[17]  R. Bellomo,et al.  High Protein Intake during Continuous Hemodiafiltration: Impact on Amino Acids and Nitrogen Balance , 2002, The International journal of artificial organs.

[18]  M. Levy,et al.  Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.

[19]  J. Kellum Primum non nocere and the meaning of modern critical care , 1998 .

[20]  Clark Wr,et al.  Azotemia control by extracorporeal therapy in patients with acute renal failure. , 1995 .

[21]  R. Bellomo,et al.  High-volume haemofiltration in human septic shock , 2001, Intensive Care Medicine.

[22]  S. Mitzner,et al.  Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. , 2001, Journal of the American Society of Nephrology : JASN.

[23]  R. Bellomo,et al.  Renal replacement therapy in acute kidney injury: controversy and consensus , 2015, Critical Care.

[24]  M. Malbrain,et al.  Renal replacement therapy is an independent risk factor for mortality in critically ill patients with acute kidney injury , 2010, Critical care.

[25]  E. Paganini Dialysis is not dialysis is not dialysis! Acute dialysis is different and needs help! , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  C. Ronco,et al.  Nursing procedures during continuous renal replacement therapies: a national survey , 2015, Heart, lung and vessels.

[27]  R. Bellomo,et al.  Patient and Kidney Survival by Dialysis Modality in Critically Ill Patients with Acute Kidney Injury , 2007 .

[28]  Z. Ricci,et al.  Renal replacement therapy in neonates with congenital heart disease. , 2007, Contributions to nephrology.

[29]  A. Garg,et al.  Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury. , 2015, Kidney international.

[30]  N. N. Salama,et al.  Longitudinal Hemodiafilter Performance in Modeled Continuous Renal Replacement Therapy , 2011, Blood Purification.

[31]  J. Takala,et al.  Comparison of continuous and intermittent renal replacement therapy for acute renal failure. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[32]  K. Asehnoune,et al.  Effect of Oropharyngeal Povidone-Iodine Preventive Oral Care on Ventilator-Associated Pneumonia in Severely Brain-Injured or Cerebral Hemorrhage Patients: A Multicenter, Randomized Controlled Trial* , 2014, Critical care medicine.

[33]  R. Bellomo,et al.  Dose of dialysis in acute renal failure. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[34]  A. Davenport The management of renal failure in patients at risk of cerebral edema/hypoxia. , 1995, New horizons.

[35]  R. Mehta,et al.  Current Status of Renal Replacement Therapy for Acute Renal Failure , 1999, American Journal of Nephrology.

[36]  C. Ronco,et al.  THE CLINICAL APPLICATION OF CRRT—CURRENT STATUS: Modalities of Continuous Renal Replacement Therapy: Technical and Clinical Considerations , 2009, Seminars in dialysis.

[37]  H. Yasuda,et al.  Validity of Low-Intensity Continuous Renal Replacement Therapy* , 2013, Critical care medicine.

[38]  W Silvester,et al.  A prospective, multicenter study of the epidemiology, management, and outcome of severe acute renal failure in a "closed" ICU system. , 2000, American journal of respiratory and critical care medicine.

[39]  T. Strasser,et al.  Biocompatible membranes in acute renal failure: prospective case-controlled study , 1994, The Lancet.

[40]  R. Bellomo,et al.  Anticoagulant regimens in acute continuous hemodiafiltration: a comparative study , 2005, Intensive Care Medicine.

[41]  A. Davenport,et al.  Volume Management by Renal Replacement Therapy in Acute Kidney Injury , 2008, The International journal of artificial organs.

[42]  S. Romagnoli,et al.  Renal replacement therapy for critically ill patients: an intermittent continuity , 2014, Critical Care.

[43]  R. Bellomo,et al.  An observational study fluid balance and patient outcomes in the randomized evaluation of normal vs. augmented level of replacement therapy trial* , 2012, Critical care medicine.

[44]  J. Conger Does Hemodialysis Delay Recovery from Acute Renal Failure? , 1990 .

[45]  J. Buckmaster,et al.  Guidelines for drug dosing during continuous renal replacement therapy , 1998 .

[46]  H E de Wardener,et al.  Effect of urinary extracts from salt-loaded man on urinary sodium excretion by the rat. , 1972, Kidney international.

[47]  G. Dobos,et al.  Anticoagulation in Continuous Renal Replacement Procedures , 1992 .

[48]  P. Palevsky Renal replacement therapy in acute kidney injury. , 2013, Advances in chronic kidney disease.

[49]  M. Tonelli,et al.  Renal replacement therapy in patients with acute renal failure: a systematic review. , 2008, JAMA.

[50]  R. Bellomo,et al.  Continuous renal replacement therapy: A worldwide practice survey , 2007, Intensive Care Medicine.

[51]  S. Bagshaw,et al.  A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis , 2011, Critical care.

[52]  E. Paganini,et al.  Critical care dialysis--a Gordian knot (but is untying the right approach?). , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[53]  A. Garg,et al.  The Association Between Renal Replacement Therapy Modality and Long-Term Outcomes Among Critically Ill Adults With Acute Kidney Injury: A Retrospective Cohort Study* , 2014, Critical care medicine.

[54]  C. Ronco,et al.  Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration. , 1995, Critical care medicine.

[55]  C. Ronco The Charta of Vicenza , 2015, Blood Purification.

[56]  R. Bellomo,et al.  Brain density changes during renal replacement in critically ill patients with acute renal failure. Continuous hemofiltration versus intermittent hemodialysis. , 1999, Journal of nephrology.

[57]  T. Ikizler,et al.  Anticoagulation, delivered dose and outcomes in CRRT: The program to improve care in acute renal disease (PICARD) , 2014, Hemodialysis international. International Symposium on Home Hemodialysis.

[58]  R. Bellomo,et al.  Hemodialysis membrane with a high-molecular-weight cutoff and cytokine levels in sepsis complicated by acute renal failure: a phase 1 randomized trial. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[59]  J. Carcillo,et al.  Plasma Filtration on Mediators of Thrombotic Microangiopathy: An in Vitro Study , 2007, The International journal of artificial organs.

[60]  R. Bellomo,et al.  Insertion Side, Body Position and Circuit Life during Continuous Renal Replacement Therapy with Femoral Vein Access , 2010, Blood Purification.

[61]  R. Bellomo,et al.  Acute renal replacement in the intensive care unit: now and tomorrow. , 1995, New horizons.

[62]  H. O. Oudemans-van Straaten Primum non nocere, safety of continuous renal replacement therapy , 2007, Current opinion in critical care.

[63]  R. Bellomo,et al.  Prolonged Daily Intermittent Renal Replacement Therapy in ICU Patients by ICU Nurses and ICU Physicians , 2004 .

[64]  T. Ikizler,et al.  Timing of initiation of dialysis in critically ill patients with acute kidney injury. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[65]  C. Ronco,et al.  Timing, dose and mode of dialysis in acute kidney injury , 2011, Current opinion in critical care.

[66]  R. Bellomo,et al.  Discontinuation of continuous renal replacement therapy: A post hoc analysis of a prospective multicenter observational study* , 2009, Critical care medicine.

[67]  A. Garg,et al.  Optimal Mode of clearance in critically ill patients with Acute Kidney Injury (OMAKI) - a pilot randomized controlled trial of hemofiltration versus hemodialysis: a Canadian Critical Care Trials Group project , 2012, Critical Care.

[68]  G. Martin Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes , 2012, Expert review of anti-infective therapy.

[69]  Yen-Hung Lin,et al.  Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy , 2007, Intensive Care Medicine.

[70]  R. Bellomo,et al.  Nomenclature for continuous renal replacement therapies , 1996 .

[71]  A. Tolwani Continuous renal-replacement therapy for acute kidney injury. , 2012, The New England journal of medicine.

[72]  R. Bellomo Continuous hemofiltration as blood purification in sepsis. , 1995, New horizons.

[73]  R. Bellomo,et al.  High volume hemofiltration , 2000, Contributions to nephrology.

[74]  N. Selby,et al.  A systematic review of the clinical effects of reducing dialysate fluid temperature. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[75]  R. Bellomo,et al.  Acute Renal Failure and Multiple Organ Dysfunction in the ICU: From Renal Replacement Therapy (RRT) to Multiple Organ Support Therapy (MOST) , 2002, The International journal of artificial organs.

[76]  R. W. Pryor,et al.  Effects of filter pore size on efficacy of continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. , 1998, Critical care medicine.

[77]  R. Bellomo,et al.  Impact of Continuous Veno-venous Hemofiltration on Acid-base Balance , 2003, The International journal of artificial organs.

[78]  R. Bellomo,et al.  Continuous veno‐venous hemofiltration with dialysis removes cytokines from the circulation of septic patients , 1993, Critical care medicine.

[79]  J. Chiche,et al.  Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial , 2006, The Lancet.

[80]  H. Sieberth History and development of continuous renalreplacement therapy (CRRT) , 1998 .

[81]  R. Bellomo,et al.  Adequacy of Dialysis in the Acute Renal Failure of the Critically ILL: The Case for Continuous Therapies , 1996, The International journal of artificial organs.

[82]  D. Matthaei,et al.  Arteriovenous haemofiltration: A new and simple method for treatment of over-hydrated patients resistant to diuretics , 1977, Klinische Wochenschrift.

[83]  C. Ronco,et al.  Renal replacement therapies: physiological review , 2008, Intensive Care Medicine.

[84]  Raymond Vanholder,et al.  Review on uremic toxins: classification, concentration, and interindividual variability. , 2003, Kidney international.

[85]  J. Kellum,et al.  Dialysis: Results of RENAL—what is the optimal CRRT target dose? , 2010, Nature Reviews Nephrology.

[86]  T. Golper,et al.  Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[87]  F. Granath,et al.  Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure , 2007, Intensive Care Medicine.

[88]  D. Fliser,et al.  Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[89]  M. Byrne,et al.  Citrate Vs. Heparin For Anticoagulation In Continuous Venovenous Hemofiltration: A Prospective Randomized Study. , 2004 .

[90]  Rinaldo Bellomo,et al.  Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial , 2000, The Lancet.

[91]  R. Bellomo,et al.  Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis , 2013, Intensive Care Medicine.

[92]  M. Griffin,et al.  Continuous versus intermittent renal replacement therapy: a meta-analysis , 2001, Intensive Care Medicine.

[93]  T. Perneger,et al.  Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. , 2006, Kidney international.

[94]  H. Yasuda,et al.  Who may not benefit from continuous renal replacement therapy in acute kidney injury? , 2013, Hemodialysis international. International Symposium on Home Hemodialysis.

[95]  C. Ronco,et al.  Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion , 2006, Critical care.

[96]  T. Depner,et al.  Extended daily dialysis: A new approach to renal replacement for acute renal failure in the intensive care unit. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[97]  Sudhir V. Shah,et al.  Development of a clinical research agenda for acute kidney injury using an international, interdisciplinary, three-step modified Delphi process. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[98]  John A Kellum,et al.  The first international consensus conference on continuous renal replacement therapy. , 2002, Kidney international.

[99]  F. Shann,et al.  Continuous plasmafiltration in sepsis syndrome , 1999 .

[100]  S. Bagshaw,et al.  Timing of RRT based on the presence of conventional indications. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[101]  R. Bellomo,et al.  Cytokine Removal during Continuous Renal Replacement Therapy: An Ex Vivo Comparison of Convection and Diffusion , 2004, The International journal of artificial organs.

[102]  R. Oster,et al.  Standard versus high-dose CVVHDF for ICU-related acute renal failure. , 2008, Journal of the American Society of Nephrology : JASN.

[103]  T. Golper,et al.  Hybrid renal replacement modalities for the critically ill. , 2001, Contributions to nephrology.

[104]  C. Ronco,et al.  In vivo validation of the adequacy calculator for continuous renal replacement therapies , 2005, Critical care.

[105]  S. Bagshaw,et al.  High-volume hemofiltration for septic acute kidney injury: a systematic review and meta-analysis , 2014, Critical Care.

[106]  S. Bagshaw,et al.  Hemofiltration compared to hemodialysis for acute kidney injury: systematic review and meta-analysis , 2012, Critical Care.

[107]  M. Mathru Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients , 2010 .

[108]  C. Winearls,et al.  Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. , 2002, The New England journal of medicine.

[109]  S. Yamada,et al.  In Vitro Evaluation of High Mobility Group Box 1 Protein Removal with Various Membranes for Continuous Hemofiltration , 2011, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[110]  Anthony Delaney,et al.  Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: A meta-analysis* , 2008, Critical care medicine.

[111]  R. Bellomo,et al.  Future technology for continuous renal replacement therapies , 1996 .

[112]  Tze-Wah Kao,et al.  Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery , 2009, Critical care.

[113]  Didier Payen,et al.  A positive fluid balance is associated with a worse outcome in patients with acute renal failure , 2008, Critical care.

[114]  John A Kellum,et al.  Acute renal failure in critically ill patients: a multinational, multicenter study. , 2005, JAMA.

[115]  C. Ronco,et al.  Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury , 2009, Critical care.

[116]  John A Kellum,et al.  Clinical review: Blood purification for sepsis , 2011, Critical care.

[117]  R. Hakim Clinical implications of hemodialysis membrane biocompatibility. , 1993, Kidney international.

[118]  Frank A. Gotch,et al.  Principles and Biophysics of Dialysis , 1996 .

[119]  J. De Sutter,et al.  Cytokine removal during continuous hemofiltration in septic patients. , 1999, Journal of the American Society of Nephrology : JASN.

[120]  J. Fortenberry,et al.  Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[121]  L. Brochard,et al.  Hemodynamic tolerance of intermittent hemodialysis in critically ill patients: usefulness of practice guidelines. , 2000, American journal of respiratory and critical care medicine.

[122]  R. Bellomo,et al.  Cytokine Dialysis: An Ex Vivo Study , 2002, ASAIO journal.

[123]  R. Bellomo,et al.  Continuous Renal Replacement Technology: From Adaptive Technology and Early Dedicated Machines towards Flexible Multipurpose Machine Platforms , 2004, Blood Purification.

[124]  R. Bellomo,et al.  Coupled plasma filtration adsorption in the treatment of septic shock. , 2001, Contributions to nephrology.

[125]  M. Wratten,et al.  Coupled plasma filtration adsorption. , 2007, Contributions to nephrology.

[126]  J. Tijssen,et al.  Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: A prospective, randomized trial , 2002, Critical care medicine.

[127]  R. Bellomo,et al.  Intermittent versus continuous renal replacement therapy in the ICU: impact on electrolyte and acid-base balance , 2001, Intensive Care Medicine.

[128]  R. Bellomo,et al.  Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. , 2009, Journal of critical care.

[129]  G. Kleger,et al.  Can Circuit Lifetime be a Quality Indicator in Continuous Renal Replacement Therapy in the Critically Ill? , 2010, The International journal of artificial organs.

[130]  C. Guérin,et al.  Intermittent versus continuous renal replacement therapy for acute renal failure in intensive care units: results from a multicenter prospective epidemiological survey , 2002, Intensive Care Medicine.

[131]  R. Bellomo,et al.  Super high flux hemofiltration: a new technique for cytokine removal , 2002, Intensive Care Medicine.

[132]  Xuan Wang,et al.  Timing of Initiation of Renal Replacement Therapy in Acute Kidney Injury: A Systematic Review and Meta-analysis , 2012, Renal failure.

[133]  L. Henderson,et al.  Biophysics of Ultrafiltration and Hemofiltration , 1996 .

[134]  M. Antonelli Polymyxin B Hemoperfusion in Clinical Practice: The Picture from an Unbound Collaborative Registry , 2014, Blood Purification.

[135]  R. Bellomo,et al.  Continuous veno-venous hemofiltration without anticoagulation in high-risk patients , 2000, Intensive Care Medicine.

[136]  R. Bellomo,et al.  Low-dose Citrate Continuous Veno-venous Hemofiltration (CVVH) and Acid-base Balance , 2005, The International journal of artificial organs.